Literature DB >> 1391981

Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells.

J B Adams1, R Vrahimis, N Phillips.   

Abstract

The importance of the steroid hormone microenvironment within cells is now recognised in studies on endocrine-related neoplasms such as breast cancer. This focuses attention on enzymes which control the intracellular levels of estradiol-17 beta (E2). One such enzyme, estrogen sulfotransferase, which converts E2 to inactive E2-3 sulfate, has now been shown to be regulated by estrogen in MCF-7 human mammary cancer cells. Hydroxysteroid sulfotransferase, which sulfurylates the adrenal-derived estrogen 5-androstene-3 beta,17 beta-diol, is also under estrogen control. Evidence is provided which shows that one function of these enzymes may involve elimination of estrogen from the cell following processing of the ligand-charged estrogen receptor (ER).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391981     DOI: 10.1007/bf01833346

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture.

Authors:  A Gompel; C Malet; P Spritzer; J P Lalardrie; F Kuttenn; P Mauvais-Jarvis
Journal:  J Clin Endocrinol Metab       Date:  1986-11       Impact factor: 5.958

3.  Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells--relationship between processing and estrogenicity.

Authors:  M Gyling; G Leclercq
Journal:  J Steroid Biochem       Date:  1988-01       Impact factor: 4.292

4.  Nuclear estrogen receptors. Effect of inhibitors on processing and steady state levels.

Authors:  K B Horwitz; W L McGuire
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

5.  Properties of estrogen and hydroxysteroid sulphotransferases in human mammary cancer.

Authors:  J B Adams; N S Phillips
Journal:  J Steroid Biochem       Date:  1990-08-28       Impact factor: 4.292

6.  Induction of estrogen sulfotransferase in the human endometrium by progesterone in organ culture.

Authors:  C L Clarke; J B Adams; B G Wren
Journal:  J Clin Endocrinol Metab       Date:  1982-07       Impact factor: 5.958

7.  Steroidal regulation of oestradiol-17 beta dehydrogenase activity of the human breast cancer cell line MCF-7.

Authors:  E F Adams; N G Coldham; V H James
Journal:  J Endocrinol       Date:  1988-07       Impact factor: 4.286

8.  A correlative morphologic study of human breast and endometrium in the menstrual cycle.

Authors:  T A Longacre; S A Bartow
Journal:  Am J Surg Pathol       Date:  1986-06       Impact factor: 6.394

9.  Metabolic fate of estradiol in human mammary cancer cells in culture: estrogen sulfate formation and cooperativity exhibited by estrogen sulfotransferase.

Authors:  J B Adams; N S Phillips; R Hall
Journal:  Mol Cell Endocrinol       Date:  1988-08       Impact factor: 4.102

10.  Stimulation of arylsulfotransferase activity by progestins in human endometrium in vitro.

Authors:  L Tseng; H C Liu
Journal:  J Clin Endocrinol Metab       Date:  1981-08       Impact factor: 5.958

View more
  3 in total

1.  The relationship of urinary and plasma androgens to steroid receptors and menopausal status in breast cancer patients and their influence on survival.

Authors:  B H Mason; I M Holdaway; S J Skinner; R G Kay
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 2.  Predicting health effects of exposures to compounds with estrogenic activity: methodological issues.

Authors:  R Rudel
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

Review 3.  Environmental pollutants and breast cancer.

Authors:  Julia Green Brody; Ruthann A Rudel
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.